Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms, Castration-Resistant × ipatasertib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Ovarian Neoplasms 4 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

enzalutamide 11 Prednisone 6 Docetaxel 6 Abiraterone Acetate 4 darolutamide 3 olaparib 2 niraparib 2 abiraterone 2 Nivolumab 2 zimberelimab 1 xentuzumab 1 sacituzumab govitecan 1 radium Ra 223 dichloride 1 quemliclustat 1 ibrutinib 1 gedatolisib 1 fludrocortisone acetate 1 cabazitaxel 1 TVB-2640 1 Rosuvastatin Calcium 1 Pluvicto 1 Pioglitazone 1 Omeprazole 1 JNJ-64619178 1 JNJ-64264681 1 Ipilimumab 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1 CTLA-4 Antigen 1 Artificial Intelligence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡